Bank Vontobel AG Stock

Certificat

RMACOV

CH1255347424

Market Closed - Swiss Exchange 11:20:00 2023-10-03 am EDT
95.5 EUR -1.44% Intraday chart for Bank Vontobel AG
1 month-3.92%
3 months-5.26%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Static data

Product typeCertificati Azionari e Obbl.ri
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMACOV
ISINCH1255347424
Date issued 2023-05-03
Strike 281.1 CHF
Maturity 2025-05-05 (303 Days)
Parity 0.28 : 1
Emission price 100
Emission volume N/A
Settlement entrambi
Currency EUR

Technical Indicators

Highest since issue 101.8
Lowest since issue 95.5

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
243.3 CHF
Average target price
276.6 CHF
Spread / Average Target
+13.70%
Consensus
  1. Stock Market
  2. Certificates
  3. RMACOV Certificat